Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received…
Tag: Biopharma
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion
By Dominique Patton and Geert De Clercq PARIS (Reuters) -France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for…
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…